Optimized structural support in catheter insertion systems

Information

  • Patent Grant
  • 12357794
  • Patent Number
    12,357,794
  • Date Filed
    Tuesday, December 21, 2021
    4 years ago
  • Date Issued
    Tuesday, July 15, 2025
    7 months ago
Abstract
Embodiments disclosed herein are directed to catheter placement systems including distally extendable support devices. When placing elongate catheters advanced insertion systems are required to maintain a “touch-free” insertion. Further longer needles are desirable to access deeper veins or penetrate deeper surface tissues. Distally extendable support devices provide columnar support to one of the elongate catheter or the needle to prevent buckling or kinking of the catheter, and maintain the needle tip within a predetermined bending arm distance. This prevents the user from contacting one of the needle or the catheter directly to provide additional support, maintaining a “touch-free” insertion.
Description
SUMMARY

Briefly summarized, embodiments disclosed herein are directed to optimized structural support devices for catheter insertion systems, and associated methods thereof. Conventional methods of placing elongate catheters, such as central venous catheters (CVC), rapid insertion central catheters (RICC), or the like, require repeated insertion and removal of multiple devices from the insertion site, and direct handling of the placement tools, catheters, devices etc. that enter the patient. Direct handling of these devices during insertion is often required to prevent buckling or kinking when an axial force is applied.


Advanced catheter insertion systems have been developed that include housings, needles, guidewires, dilators, and/or blood flash indicators configured to access the vasculature, confirm correct vascular access, dilate the insertion site and place the catheter. Advantageously, such advanced catheter insertion systems can contain the aforementioned structures within an enclosed environment to enable a “touch-free” placement of the catheter and mitigate the introduction of pathogens. Nonetheless, these insertion systems can still leave a portion of the catheter unsupported during placement, exposing the catheter to buckling or kinking when urged axially into the insertion site.


Further, when accessing the vasculature to place the catheter, a longer needle length is desirable to accommodate a broader patient base. The longer needle length can access deeper veins or penetrate deeper surface tissues. However, longer needles provide longer bending arms, i.e. a length of unsupported needle. A shorter needle bending arm, i.e. a shorter unsupported needle length, is preferable since this provides less flexion, increased accuracy, and increased tactile feedback to the clinician when accessing the vasculature. Since these advanced catheter insertion systems are provided with a needle “pre-loaded,” needle exchange is not feasible and either an entirely different system must be provided to suit different patients, e.g. pediatric or adult, or a clinician must support the needle by manipulating needle itself as it enters the body, risking infection. Embodiments disclosed herein are directed to catheter placement systems with increased structural support devices to resolve the aforementioned problems.


Disclosed herein is a catheter placement system including, a needle supported by a needle hub, a catheter defining a catheter lumen, the needle extending through a portion of the catheter lumen, and a housing including, a body, a catheter advancement assembly releasably engaged with a hub of the catheter, the catheter advancement assembly slidably engaged with the body between a proximal position, a medial position, and a distal position, and a distal support slidably engaged with the body between a retracted position and an extended position, the distal support including a nose portion defining a channel to receive a portion of the catheter therethrough.


In some embodiments, the distal support is configured to transition the catheter assembly from the proximal position to the medial position as the distal support is transitioned from the retracted position to the extended position. In some embodiments, the catheter advancement assembly is configured to transition the distal support from the retracted position to the extended position as the catheter advancement assembly is transitioned from the medial position to the distal position. In some embodiments, the catheter advancement assembly includes an abutment and the body includes a cam surface, the abutment configured to engage the cam surface to urge a first portion of the body laterally apart from a second portion of the body, as the catheter advancement assembly is transitioned from the medial position to the distal position.


In some embodiments, the nose portion includes a door hingedly engaged therewith, and rotatable to an open position to allow egress of the portion of the catheter from the channel. The distal support is configured to extend distally from the housing to maintain the nose portion within a predetermined distance from a tip of the needle. The predetermined distance is a needle bending arm length of 7 cm or less. In some embodiments, the catheter placement system further includes a blood flash indicator configured to receive a blood flow from the needle lumen. In some embodiments, the catheter is a CVC catheter or a RICC catheter.


Also disclosed is a method of placing a catheter within a vasculature of a patient including, accessing the vasculature with a needle, the needle extending from a housing and including a portion of the catheter disposed annularly thereon, sliding a catheter advancement assembly from a proximal position to a medial position to advance a portion of the catheter into the vasculature, actuating a distal support from a retracted position to an extended position, advancing the catheter advancement assembly from the medial position to a distal position, separating a first portion of the housing laterally apart from a second portion of the housing, and disengaging the housing transversely upward from the catheter.


In some embodiments, the catheter advancement assembly includes an abutment configured to engage a cam surface of the housing body to separate the first portion of the housing laterally apart from the second portion of the housing, as the catheter advancement assembly transitions from the medial position to the distal position. In some embodiments, the distal support includes a nose portion defining a channel and is slidably engaged with the catheter, the nose portion providing rigid columnar support to a portion of the catheter as the catheter advancement assembly transitions from the medial position to the distal position. In some embodiments, the nose portion includes a door hingedly coupled thereto and configured to transition from a closed position to an open position to allow egress of the catheter from the channel along an axis perpendicular to a longitudinal axis.


In some embodiments, the method further includes withdrawing a needle proximally, prior to advancing the catheter advancement assembly from the proximal position. In some embodiments, the catheter advancement assembly releasably engages a portion of the catheter in an interference fit, press-fit, or snap-fit engagement. In some embodiments, the method further includes extending the distal support distally from the housing to maintain the nose portion within a predetermined distance from a tip of the needle. In some embodiments, the predetermined distance is a needle bending arm length of 7 cm or less. In some embodiments, the method further includes sliding a blood flash indicator along a longitudinal axis to create a vacuum and draw a blood flow through a lumen of the needle. In some embodiments, the catheter is a CVC catheter or a RICC catheter.





DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1A shows a perspective view of an exemplary catheter insertion system, in accordance with embodiments disclosed herein.



FIG. 1B shows a side view of an exemplary catheter insertion system, in accordance with embodiments disclosed herein.



FIG. 1C shows a plan view of an exemplary catheter insertion system, in accordance with embodiments disclosed herein.



FIG. 2A shows an exploded view of an exemplary catheter insertion system, in accordance with embodiments disclosed herein.



FIG. 2B shows an exploded view of a housing of an exemplary catheter insertion system, in accordance with embodiments disclosed herein.



FIGS. 3A-3J show an exemplary method of use for a catheter insertion system, in accordance with embodiments disclosed herein.





DESCRIPTION

Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.


Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


In the following description, the terms “or” and “and/or” as used herein are to be interpreted as inclusive or meaning any one or any combination. As an example, “A, B or C” or “A, B and/or C” mean “any of the following, A, B, C, A and B, A and C, B and C, A, B and C.” An exception to this definition will occur only when a combination of elements, components, functions, steps or acts are in some way inherently mutually exclusive.


With respect to “proximal,” a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.


With respect to “distal,” a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.


To assist in the description of embodiments described herein, as shown in FIG. 1A, a longitudinal axis extends substantially parallel to an axial length of the catheter. A lateral axis extends normal to the longitudinal axis, and a transverse axis extends normal to both the longitudinal and lateral axes. A horizontal plane can be defined by the longitudinal and lateral axes, a vertical plane can extend perpendicular to the horizontal plane. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.



FIGS. 1A-2A show an exemplary catheter insertion system (“system”) 100, generally including a needle 110, a catheter 120, a housing 130, and a blood flash indicator 150. Optionally, the insertion system 100 can further include one or more guidewires (not shown). The needle 110 can define a needle lumen 114 and is supported by a needle hub 112 disposed at a proximal end thereof. The needle 110 can be configured to extend through at least a portion of a lumen of the catheter 120. A distal tip 116 of the needle 110 can extend distally of the distal tip of the catheter 120 and can define a sharpened tip configured for skin puncture and vascular access.


The catheter 120 can be a central venous catheter (CVC), a rapid insertion central catheter (RICC), or similar elongate catheter configured to provide access to a vasculature of a patient. As shown in FIG. 2A, the catheter 120 can be a RICC catheter 120 including an access section 162 defining a first diameter, a dilation section 164, and a catheter body section 166 defining a second diameter, larger than the first diameter.


The access section 162 can define a single lumen and can be formed of a harder durometer material relative to the catheter body section 166. The catheter body section 166 can define one or more lumen and can be formed of a softer, more compliant material relative to the access section 162. The dilation section 164 can be formed of either the same material as the access section 162, or of a third material. The third material can be of a harder durometer relative to the material of the catheter body section 166. The dilation section 164 can provide a tapered transition between the first diameter of the access section 162 and the second diameter of the catheter body section 166. The access section 162 and the dilation section 164 can provide relatively more rigid mechanical properties and can be relatively more resistant to kinking or collapsing when an axial force is applied thereto, relative to the catheter body section 166. The catheter body section 166 can be relatively more compliant to facilitate negotiating tortuous vascular pathways. In an embodiment, the catheter 120 can further include a hub 168, a bifurcation 170, and/or one or more extension 172 legs each communicating with a lumen of the catheter 120. In an embodiment, the needle 110 can extend through an extension leg 172, through a lumen of the catheter body section 166 and through a lumen of the access section 162 to extend distally of a distal tip of the catheter 120.


The catheter insertion system 100 can further include a housing 130 configured to support the needle 110 and the catheter 120, as described in more detail herein. The catheter insertion system 100 can further include a blood flash indicator 150 in fluid communication with the needle lumen 114. The blood flash indicator 150 can include a container configured to receive a blood flow therein. The container can be formed of a transparent material to allow a user to observe a color and pulsatile flow disposed therein. In an embodiment, the blood flash indicator can include a vacutainer configured to maintain a vacuum therein to facilitate drawing a blood flow proximally through the needle lumen 114 and into the vacutainer.


In an embodiment, the blood flash indicator 150 can include a syringe barrel 154 and a plunger 156, slidably engaged therewith and configured to create a vacuum to draw a blood flow proximally through the needle lumen 114 and into the syringe barrel 154. In an embodiment, the plunger 156 can be fixedly engaged with the housing 130 to prevent any longitudinal movement relative thereto. The plunger 156 can be engaged with the housing 130 with an interference fit, snap-fit, press-fit engagement, adhesive, weld, bonding, or the like. The syringe barrel 154 can be supported by a barrel cradle 158. The barrel 154 and barrel cradle 158 assembly can be slidable relative to the plunger 156 and housing 130 assembly, and configured such that sliding the barrel 154 and cradle 158 assembly proximally can create a vacuum within the barrel 154. In an embodiment, the barrel cradle 158 can be formed of a transparent material.


In an embodiment, the blood flash indicator 150 can be fluidly coupled with the needle lumen 114 by way of a flexible tube 152, or the like. Advantageously, the flexible tube 152 can allow the syringe barrel to slide proximally relative to the needle interface 140. Advantageously, by reversing the operation of the syringe blood flash indicator 150, the syringe barrel 154 can be slid proximally to create the vacuum and reduce a length of the fluid path between the blood flash indicator 150 and the needle tip 116. Further, the action of the syringe barrel 154 and plunger 156 still allows a clinician to leverage the tactile and visual feedback offered via syringe-based blood flashback systems. Advantageously, moving the syringe barrel 154 proximally moves the barrel 154 away from the distal end of the insertion device 100 providing a clearer line of sight at the insertion site and allows for operations to occur, for example the manipulation of guidewire advancement assemblies, catheter advancement assemblies, hinging housing portions, or the like.


In use, a clinician can access a vasculature by inserting a needle tip 116 and a distal portion of the access section 162 into the vasculature. A blood flow can flow proximally through the needle lumen 114 to a blood flash indicator 150. A color and pulsatile flow can be observed to confirm correct vascular access. In case of incorrect vascular access, the access section 162 can be withdrawn and the insertion site closed by applying pressure, due to the relatively small diameter of the access section 162. Where correct vascular access is confirmed, the catheter 120 can be advanced, optionally over a guidewire, until a dilation section 164 enters the insertion site and dilates the insertion site to the second diameter of the catheter body section 166. The catheter body section 166 can then be advanced until a distal portion of the catheter is at a target location within the vasculature. Further details of RICC catheters and associated insertion systems and methods can be found in U.S. Pat. No. 10,376,675; U.S. Patent Publications U.S. 2019/0255294, U.S. 2021/0069471, U.S. 2021/0085927, U.S. 2021/0113809, U.S. 2021/0113810, U.S. 2021/0121661, U.S. 2021/0121667, U.S. 2021/0228843, U.S. 2021/0322729, U.S. 2021/0330941, U.S. 2021/0330942, and U.S. 2021/0361915, each of which are incorporated by reference in its entirety into this application.



FIG. 2B shows further details of the housing 130 generally including a body 132, a distal support 134, a catheter advancement assembly 136 and a blood flash indicator 150. The housing 130 can include a body 132 including a needle interface 140 disposed at a proximal end and configured to provide fluid communication between the needle lumen 114 and the blood flash indicator 150 by way of an aperture 118 disposed in a wall of the needle 110. A distal support 134 can be slidably engaged with the body 132 along a longitudinal axis between a retracted position (FIG. 3D) and an extended position (FIG. 3E). The distal support 134 can include a handle 178 configured to allow a user to grasp the distal support 134 and transition the distal support 134 between the retracted position and the extended position.


The distal support 134 can further include a nose portion 180 disposed at a distal end and defining a channel 182 extending along the longitudinal axis and configured to receive a portion of the catheter 120 therethrough. The catheter 120 can be slidably engaged with the channel 182. As such, the distal support 134 can engage the catheter 120 and provide a rigid, columnar support to the catheter 120 to prevent buckling or kinking of the catheter 120 when a longitudinal axial force is applied. Further, as described in more detail herein, the distal support 134 can extend distally to support a portion of the catheter 120 that has been advanced from the housing 130. This can provide columnar support to the catheter 120 while preventing a user from having to touch portions of the catheter 120 that are intended to enter the body of the patient.


In like manner, the distal support 134 can also provide rigid support to a portion of the needle 110. As described herein, while a longer needle can be advantageous to accommodate a broader patient base, access deeper veins, or penetrate deeper surface tissues, a shorter bending arm (x) (FIG. 1A) is preferred to provide improved accuracy, and improved tactile feedback. Typically a bending arm (x) length of 7 cm or less is preferred however, greater or lesser lengths are also contemplated depending on the material or structure of the needle 110. As such, where a needle tip 116 is extended from the housing 130 beyond the predetermined bending arm length (x), a user can extend the distal support 134 to provide a ridged support to the needle 110 within the predetermined bending arm length (x) from the needle tip 116.


In an embodiment, the nose portion 180 can include one or more doors 138 hingedly coupled with the distal support 134. In an embodiment, as shown in FIG. 3I, the door(s) 138 can rotate through an arc extending through a vertical plane, perpendicular to the longitudinal axis between a closed position and an open position. In an embodiment, as shown in FIG. 3H, the door(s) 138 can rotate laterally through an arc extending through a horizontal plane, between a closed position and an open position. In the closed position, the door 138 can prevent egress of the portion of catheter 120 from the channel 182. In the opening position, the door 138 can allow ingress or egress of the portion of catheter 120 to/from the channel 182.


In an embodiment, the catheter advancement assembly 136 can be slidably engaged with the body 132 along the longitudinal axis between a proximal position (FIG. 3C), a medial position (FIG. 3D), and a distal position (FIG. 3E). The catheter advancement assembly 136 can releasably engage a portion of the catheter 120. For example, the catheter advancement assembly 136 can releasably retain the catheter hub 168 in an interference fit, press-fit, or snap-fit engagement. However it will be appreciated that other mechanisms to releasably engage the catheter 120 are also contemplated. Further, it will be appreciated that the catheter advancement assembly 136 can engage other portions of the catheter 120, for example, the catheter body section 166, the bifurcation 170, combinations thereof, or the like. Sliding the catheter advancement assembly 136 between the proximal position, medial position, and distal position can advance the catheter 120 along a longitudinal axis.



FIGS. 3A-3J show an exemplary method of use for the catheter insertion system 100. As shown in FIG. 3A, a user can grasp the housing 130 and advance a needle tip 116 through a skin surface 80 of the patient to create an insertion site 90 and access a vasculature of the patient therebelow. As described herein, the needle tip 116 can extend from the housing 130 by a predetermined distance (x). The predetermined distance (x), i.e., needle bending arm, will be within a tolerance to provide support to the needle 110, but to prevent bending or breaking of the needle 110 when a force is applied. In an embodiment, the predetermined distance (x) is equal to or less then 7 cm, however, greater or lesser values are also contemplated. As will be appreciated, the predetermined distance (x) can vary depending on the structure and material of the needle 110.


As shown in FIG. 3B, a user can actuate a barrel cradle 158 to slide the syringe barrel 154 in a proximal direction relative to the housing body 132. The plunger 156, being coupled to the housing body 132, remains stationary relative to the housing 130, as the barrel 154 slides proximally, creating a vacuum within the syringe barrel 154. The vacuum draws a blood flow proximally through the needle lumen 114, through the needle aperture 118, through the needle interface 140, through the flexible tube 152 and into the syringe barrel 154. As noted herein, the syringe barrel 154 and optionally the barrel cradle 158 can be formed of a transparent material to facilitate observation of the blood flow color and pulsatile flow.


As shown in FIG. 3C, once vascular access has been confirmed, the needle hub 112 can be withdrawn proximally to withdraw the tip 116 proximally of the distal tip of the catheter 120. In an embodiment, the needle 110 can be withdrawn further, for example, so that the needle tip 116 is proximal of one of the access section 162, dilation section 164, the catheter body section 166, the hub 168, the bifurcation 170, or withdrawn from the catheter 120 entirely.


As shown in FIG. 3D, a user can then slide the catheter advancement assembly 136 and the catheter 120, coupled thereto, from the proximal position to the medial position to advance the catheter 120 into the insertion site 90. As the dilation section 164 is urged into the insertion site 90, the insertion site 90 is dilated to the second diameter of the catheter body section 166. To note, the catheter body section 166 can include two or more lumen that each communicate with an opening disposed in a side wall of the catheter body section 166 adjacent the dilation section 164.


When the catheter advancement assembly 136 is advanced to the medial position (FIG. 3D) the distal support 134 can slide distally from the housing body 132 (FIG. 3E) from the retracted position to the extended position. In an embodiment, the catheter advancement assembly 136 can be advanced to the medial position simultaneously with the distal support 134 being advanced to the extended position. Advantageously, the simultaneous advancement of the catheter advancement assembly 136 and the distal support 134 allows the nose portion 180 to provide rigid support to the catheter 120 as the catheter 120 is advanced. In an embodiment, with the distal support 134 in the extended position, the catheter advancement assembly 136 can advance from the medial position (FIG. 3D) to the distal position (FIG. 3E). Advantageously, the catheter advancement assembly 136 and the distal support 134 can be selectively advanced by the user to advance the catheter 120 and provide support to the catheter 120 to prevent buckling or kinking of the catheter 120 without having to directly touch portions of the catheter 120 that are to enter the patient's body.


In an embodiment, the system 100 can include one or more gears, levers, or similar mechanisms to provide mechanical advantage between the longitudinal movement of one or both of the distal support 134 and the catheter advancement assembly 136 and the resulting movement of one or both of the nose portion 180 and the catheter 120. For example, as shown in FIGS. 3C-3E, a 1:1 mechanical advantage is shown where for a single unit of longitudinal distance of user input, a single unit of longitudinal distance of output is achieved, i.e. 1 cm of distal support handle 178 movement results in 1 cm of nose portion 180 movement. Similarly, 1 cm of catheter advancement assembly 136 movement results in 1 cm of catheter 120 movement. In an embodiment, the system 100 can include mechanisms to provide a 1:>1 mechanical advantage, i.e. 1 cm of distal support handle 178 movement results in >1 cm of nose portion 180 movement. Similarly, 1 cm of catheter advancement assembly 136 movement results in >1 cm of catheter 120 movement.



FIGS. 3F-3G show close up detail of an underside view of the system 100. In an embodiment, as shown in FIGS. 3F-3G, the catheter advancement assembly 136 can include an abutment surface 174 configured to engage a cam surface 176 of the housing body 132. As the catheter advancement assembly 136 transitions from the medial position (FIG. 3F) to the distal position, the abutment surface 174 can engage the cam surface 176 to urge two or more portions 132A, 132B of the housing body 132 laterally apart. Separating the housing portions 132A, 132B can provide a longitudinal opening to allow the housing body 132 to disengage the catheter 120 in a transverse direction, as described in more detail herein. FIG. 3G shows an underside view of the system 100 with the catheter advancement assembly 136 in the distal position and the distal support 134 in the extended position.


As shown in FIGS. 3H-3J, with the distal support 134 in the extended position and the catheter advancement assembly 136 in the distal position, the catheter 120 is placed within the vasculature with the catheter hub 168 is disposed adjacent the insertion site 90. Advantageously, the user can place the catheter 120 as such without having to directly touch the catheter 120 distally of the catheter hub 168. Once the catheter 120 is placed, the door 138 of the nose piece 180 can rotate to an open position to allow the nose piece 180 to disengage the catheter 120 (FIGS. 3H, 3I). In an embodiment, as shown in FIG. 3H, the system 100 can include a first door 138A and a second door 138, each configured to rotate relative to the housing 130. In an embodiment, the door(s) 138 through a longitudinal axis, either through a vertical plane, a horizontal plane, or at an angle relative thereto. In an embodiment, as shown in FIG. 3I, a first door 138A can rotate relative to a second door 138B, the second door 138B remaining stationary relative to the housing 130. In an embodiment, the door 138 can rotate through an axis extending perpendicular to the longitudinal axis, e.g. a lateral vertical plane. These and other number, orientation, or configuration of doors 138 are contemplated to fall within the scope of the present invention. As shown in FIG. 3J, the housing 130 can then disengage the catheter 120 transversely upward, leaving the catheter 120 placed within the vasculature of the patient. Advantageously, the catheter placement system 100 can place the catheter 120 while maintaining axial support to prevent buckling and can prevent the user from touching any portion of the catheter.


While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims
  • 1. A catheter placement system, comprising: a needle supported by a needle hub;a catheter defining a catheter lumen, the needle extending through a portion of the catheter lumen; anda housing comprising: a body extending between a proximal end and a distal end and configured to enclose a first portion of the catheter about a longitudinal axis;a catheter advancement assembly releasably engaged with a hub of the catheter, the catheter advancement assembly slidably engaged with the body between a proximal position, a medial position, and a distal position; anda distal support slidably engaged with a distal portion of the body between a retracted position and an extended position, the distal support including a nose portion disposed at a distal end of the distal support and defining a channel to receive a second portion of the catheter therethrough, the nose portion in the retracted position disposed distally of the distal end of the body.
  • 2. The catheter placement system according to claim 1, wherein the distal support is configured to transition the catheter advancement assembly from the proximal position to the medial position as the distal support is transitioned from the retracted position to the extended position.
  • 3. The catheter placement system according to claim 1, wherein the catheter advancement assembly is configured to transition the distal support from the retracted position to the extended position as the catheter advancement assembly is transitioned from the medial position to the distal position.
  • 4. The catheter placement system according to claim 1, wherein the catheter advancement assembly includes an abutment and the body includes a cam surface, the abutment configured to engage the cam surface to urge a first portion of the body laterally apart from a second portion of the body, as the catheter advancement assembly is transitioned from the medial position to the distal position.
  • 5. The catheter placement system according to claim 1, wherein the nose portion includes a door hingedly engaged therewith, and rotatable to an open position to allow egress of the portion of the catheter from the channel.
  • 6. The catheter placement system according to claim 1, wherein the distal support is configured to extend distally from the housing to maintain the nose portion within a predetermined distance from a tip of the needle.
  • 7. The catheter placement system according to claim 6, wherein the predetermined distance is a needle bending arm length of 7 cm or less.
  • 8. The catheter placement system according to claim 1, further including a blood flash indicator configured to receive a blood flow from a lumen of the needle.
  • 9. The catheter placement system according to claim 1, wherein the catheter is a CVC catheter or a RICC catheter.
  • 10. A method of placing a catheter within a vasculature of a patient, comprising: accessing the vasculature with a needle, the needle extending from a housing and including a first portion of the catheter disposed annularly thereon, the housing including a body extending between a proximal end and a distal end and configured to enclose a second portion of the catheter about a longitudinal axis;sliding a catheter advancement assembly from a proximal position to a medial position to advance the first portion of the catheter into the vasculature;actuating a distal support from a retracted position to an extended position, the distal support slidably engaged with the body and having a nose portion disposed distally of the body in both the retracted position and the extended position;advancing the catheter advancement assembly from the medial position to a distal position;separating a first portion of the housing laterally apart from a second portion of the housing; anddisengaging the housing transversely upward from the catheter.
  • 11. The method according to claim 10, wherein the catheter advancement assembly includes an abutment configured to engage a cam surface of the body of the housing to separate the first portion of the housing laterally apart from the second portion of the housing, as the catheter advancement assembly transitions from the medial position to the distal position.
  • 12. The method according to claim 10, wherein the nose portion defines a channel and is slidably engaged with the catheter, the nose portion providing rigid columnar support to a portion of the catheter as the catheter advancement assembly transitions from the medial position to the distal position.
  • 13. The method according to claim 12, wherein the nose portion includes a door hingedly coupled thereto and configured to transition from a closed position to an open position to allow egress of the catheter from the channel along an axis perpendicular to the longitudinal axis.
  • 14. The method according to claim 10, further comprising withdrawing the needle proximally, prior to advancing the catheter advancement assembly from the proximal position.
  • 15. The method according to claim 10, wherein the catheter advancement assembly releasably engages a portion of the catheter in an interference fit, press-fit, or snap-fit engagement.
  • 16. The method according to claim 12, further comprising extending the distal support distally from the housing to maintain the nose portion within a predetermined distance from a tip of the needle.
  • 17. The method according to claim 16, wherein the predetermined distance is a needle bending arm length of 7 cm or less.
  • 18. The method according to claim 10, further comprising sliding a blood flash indicator along the longitudinal axis to create a vacuum and draw a blood flow through a lumen of the needle.
  • 19. The method according to claim 10, wherein the catheter is a CVC catheter or a RICC catheter.
PRIORITY

This application claims the benefit of priority to U.S. Provisional Application No. 63/128,694, filed Dec. 21, 2020, which is incorporated by reference in its entirety into this application.

US Referenced Citations (389)
Number Name Date Kind
1013691 Shields Jan 1912 A
3225762 Guttman Dec 1965 A
3325061 Ellsworth Jun 1967 A
3382872 Rubin May 1968 A
3570485 Reilly Mar 1971 A
3890976 Bazell et al. Jun 1975 A
3991762 Radford Nov 1976 A
4205675 Vaillancourt Jun 1980 A
4292970 Hession, Jr. Oct 1981 A
4468224 Enzmann et al. Aug 1984 A
4484915 Tartaglia Nov 1984 A
4525157 Vaillancourt Jun 1985 A
4581019 Curelaru et al. Apr 1986 A
4594073 Stine Jun 1986 A
4702735 Luther et al. Oct 1987 A
4743265 Whitehouse et al. May 1988 A
4766908 Clement Aug 1988 A
4863432 Kvalo Sep 1989 A
4935008 Lewis, Jr. Jun 1990 A
4950252 Luther et al. Aug 1990 A
4957489 Cameron et al. Sep 1990 A
4994040 Cameron et al. Feb 1991 A
5017259 Kohsai May 1991 A
5040548 Yock Aug 1991 A
5057073 Martin Oct 1991 A
5112312 Luther May 1992 A
5115816 Lee May 1992 A
5120317 Luther Jun 1992 A
5158544 Weinstein Oct 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5188593 Martin Feb 1993 A
5195962 Martin et al. Mar 1993 A
5207650 Martin May 1993 A
RE34416 Lemieux Oct 1993 E
5267958 Buchbinder et al. Dec 1993 A
5295970 Clinton et al. Mar 1994 A
5306247 Pfenninger Apr 1994 A
5312361 Zadini et al. May 1994 A
5322512 Mohiuddin Jun 1994 A
5328472 Steinke et al. Jul 1994 A
5350358 Martin Sep 1994 A
5358495 Lynn Oct 1994 A
5368567 Lee Nov 1994 A
5378230 Mahurkar Jan 1995 A
5380290 Makower et al. Jan 1995 A
5389087 Miraki Feb 1995 A
5439449 Mapes et al. Aug 1995 A
5443457 Ginn et al. Aug 1995 A
5460185 Johnson et al. Oct 1995 A
5489271 Andersen Feb 1996 A
5573520 Schwartz et al. Nov 1996 A
5683370 Luther et al. Nov 1997 A
5713876 Bogert et al. Feb 1998 A
5718678 Fleming, III Feb 1998 A
5772636 Brimhall et al. Jun 1998 A
5885251 Luther Mar 1999 A
5919164 Andersen Jul 1999 A
5921971 Agro et al. Jul 1999 A
5947940 Beisel Sep 1999 A
5951518 Licata et al. Sep 1999 A
5957893 Luther et al. Sep 1999 A
5971957 Luther et al. Oct 1999 A
6159198 Gardeski et al. Dec 2000 A
6197007 Thorne et al. Mar 2001 B1
6206849 Martin et al. Mar 2001 B1
6228062 Howell et al. May 2001 B1
6475187 Gerberding Nov 2002 B1
6551284 Greenberg et al. Apr 2003 B1
6606515 Windheuser et al. Aug 2003 B1
6616630 Woehr et al. Sep 2003 B1
6626869 Bint Sep 2003 B1
6638252 Moulton et al. Oct 2003 B2
6716228 Tal Apr 2004 B2
6726659 Stocking et al. Apr 2004 B1
6819951 Patel et al. Nov 2004 B2
6821287 Jang Nov 2004 B1
6926692 Katoh et al. Aug 2005 B2
6962575 Tal Nov 2005 B2
6991625 Gately et al. Jan 2006 B1
6994693 Tal Feb 2006 B2
6999809 Currier et al. Feb 2006 B2
7025746 Tal Apr 2006 B2
7029467 Currier et al. Apr 2006 B2
7037293 Carrillo et al. May 2006 B2
7074231 Jang Jul 2006 B2
7094222 Siekas et al. Aug 2006 B1
7141050 Deal et al. Nov 2006 B2
7144386 Korkor et al. Dec 2006 B2
7311697 Osborne Dec 2007 B2
7364566 Elkins et al. Apr 2008 B2
7377910 Katoh et al. May 2008 B2
7390323 Jang Jun 2008 B2
D600793 Bierman et al. Sep 2009 S
D601242 Bierman et al. Sep 2009 S
D601243 Bierman et al. Sep 2009 S
7594911 Powers et al. Sep 2009 B2
7691093 Brimhall Apr 2010 B2
7722567 Tal May 2010 B2
D617893 Bierman et al. Jun 2010 S
D624643 Bierman et al. Sep 2010 S
7819889 Healy et al. Oct 2010 B2
7857788 Racz Dec 2010 B2
D630729 Bierman et al. Jan 2011 S
7909797 Kennedy, II et al. Mar 2011 B2
7909811 Agro et al. Mar 2011 B2
7922696 Tal et al. Apr 2011 B2
7938820 Webster et al. May 2011 B2
7967834 Tal et al. Jun 2011 B2
7976511 Fojtik Jul 2011 B2
7985204 Katoh et al. Jul 2011 B2
8073517 Burchman Dec 2011 B1
8105286 Anderson et al. Jan 2012 B2
8192402 Anderson et al. Jun 2012 B2
8202251 Bierman et al. Jun 2012 B2
8206356 Katoh et al. Jun 2012 B2
8361011 Mendels Jan 2013 B2
8372107 Tupper Feb 2013 B2
8377006 Tal et al. Feb 2013 B2
8454577 Joergensen et al. Jun 2013 B2
8585858 Kronfeld et al. Nov 2013 B2
8657790 Tal et al. Feb 2014 B2
8672888 Tal Mar 2014 B2
8696645 Tal et al. Apr 2014 B2
8784362 Boutilette et al. Jul 2014 B2
8827958 Bierman et al. Sep 2014 B2
8876704 Golden et al. Nov 2014 B2
8882713 Call et al. Nov 2014 B1
8900192 Anderson et al. Dec 2014 B2
8900207 Uretsky Dec 2014 B2
8915884 Tal et al. Dec 2014 B2
8956327 Bierman et al. Feb 2015 B2
9023093 Pal May 2015 B2
9067023 Bertocci Jun 2015 B2
9126012 McKinnon et al. Sep 2015 B2
9138252 Bierman et al. Sep 2015 B2
9180275 Helm Nov 2015 B2
9265920 Rundquist et al. Feb 2016 B2
9272121 Piccagli Mar 2016 B2
9445734 Grunwald Sep 2016 B2
9522254 Belson Dec 2016 B2
9554785 Walters et al. Jan 2017 B2
9566087 Bierman et al. Feb 2017 B2
9675784 Belson Jun 2017 B2
9713695 Bunch et al. Jul 2017 B2
9764117 Bierman et al. Sep 2017 B2
9770573 Golden et al. Sep 2017 B2
9814861 Boutillette et al. Nov 2017 B2
9820845 von Lehe et al. Nov 2017 B2
9861383 Clark Jan 2018 B2
9872971 Blanchard Jan 2018 B2
9884169 Bierman et al. Feb 2018 B2
9889275 Voss et al. Feb 2018 B2
9913585 McCaffrey et al. Mar 2018 B2
9913962 Tal et al. Mar 2018 B2
9981113 Bierman May 2018 B2
10010312 Tegels Jul 2018 B2
10065020 Gaur Sep 2018 B2
10086170 Chhikara et al. Oct 2018 B2
10098724 Adams et al. Oct 2018 B2
10111683 Tsamir et al. Oct 2018 B2
10118020 Avneri et al. Nov 2018 B2
10130269 McCaffrey et al. Nov 2018 B2
10220184 Clark Mar 2019 B2
10220191 Belson et al. Mar 2019 B2
10265508 Baid Apr 2019 B2
10271873 Steingisser et al. Apr 2019 B2
10376675 Mitchell et al. Aug 2019 B2
10675440 Abitabilo et al. Jun 2020 B2
10688281 Blanchard Jun 2020 B2
10806901 Burkholz et al. Oct 2020 B2
10926060 Stern et al. Feb 2021 B2
11260206 Stone et al. Mar 2022 B2
11400260 Huang Aug 2022 B2
11759607 Biancarelli Sep 2023 B1
20020040231 Wysoki Apr 2002 A1
20020045843 Barker et al. Apr 2002 A1
20020198492 Miller et al. Dec 2002 A1
20030036712 Heh et al. Feb 2003 A1
20030060863 Dobak Mar 2003 A1
20030088212 Tal May 2003 A1
20030100849 Jang May 2003 A1
20030153874 Tal Aug 2003 A1
20030158514 Tal Aug 2003 A1
20040015138 Currier et al. Jan 2004 A1
20040064086 Gottlieb et al. Apr 2004 A1
20040116864 Boudreaux Jun 2004 A1
20040116901 Appling Jun 2004 A1
20040167478 Mooney et al. Aug 2004 A1
20040193093 Desmond Sep 2004 A1
20040230178 Wu Nov 2004 A1
20050004554 Osborne Jan 2005 A1
20050120523 Schweikert Jun 2005 A1
20050131343 Abrams et al. Jun 2005 A1
20050215956 Nerney Sep 2005 A1
20050215958 Hawthorne Sep 2005 A1
20050245882 Elkins et al. Nov 2005 A1
20050283221 Mann et al. Dec 2005 A1
20060009740 Higgins et al. Jan 2006 A1
20060116629 Tal et al. Jun 2006 A1
20060129100 Tal Jun 2006 A1
20060129130 Tal et al. Jun 2006 A1
20070276288 Khaw Nov 2007 A1
20080045894 Perchik et al. Feb 2008 A1
20080125744 Treacy May 2008 A1
20080125748 Patel May 2008 A1
20080132850 Fumiyama et al. Jun 2008 A1
20080262430 Anderson et al. Oct 2008 A1
20080262431 Anderson et al. Oct 2008 A1
20080294111 Tal et al. Nov 2008 A1
20080312578 DeFonzo et al. Dec 2008 A1
20080319387 Amisar et al. Dec 2008 A1
20090187147 Kurth et al. Jul 2009 A1
20090221961 Tal et al. Sep 2009 A1
20090270889 Tal et al. Oct 2009 A1
20090292272 McKinnon Nov 2009 A1
20100030154 Duffy Feb 2010 A1
20100256487 Hawkins et al. Oct 2010 A1
20100298839 Castro Nov 2010 A1
20100305474 DeMars et al. Dec 2010 A1
20110004162 Tal Jan 2011 A1
20110009827 Bierman et al. Jan 2011 A1
20110021994 Anderson et al. Jan 2011 A1
20110066142 Tal et al. Mar 2011 A1
20110071502 Asai Mar 2011 A1
20110144620 Tal Jun 2011 A1
20110152836 Riopelle et al. Jun 2011 A1
20110190778 Arpasi et al. Aug 2011 A1
20110202006 Bierman et al. Aug 2011 A1
20110251559 Tal et al. Oct 2011 A1
20110270192 Anderson et al. Nov 2011 A1
20120041371 Tal et al. Feb 2012 A1
20120065590 Bierman et al. Mar 2012 A1
20120078231 Hoshinouchi Mar 2012 A1
20120130411 Tal et al. May 2012 A1
20120130415 Tal et al. May 2012 A1
20120157854 Kurrus et al. Jun 2012 A1
20120215171 Christiansen Aug 2012 A1
20120220942 Hall et al. Aug 2012 A1
20120226239 Green Sep 2012 A1
20120283640 Anderson et al. Nov 2012 A1
20120316500 Bierman et al. Dec 2012 A1
20130053763 Makino et al. Feb 2013 A1
20130053826 Shevgoor Feb 2013 A1
20130123704 Bierman et al. May 2013 A1
20130158338 Kelly et al. Jun 2013 A1
20130188291 Vardiman Jul 2013 A1
20130237931 Tal et al. Sep 2013 A1
20130306079 Tracy Nov 2013 A1
20140025036 Bierman et al. Jan 2014 A1
20140081210 Bierman et al. Mar 2014 A1
20140094774 Blanchard Apr 2014 A1
20140100552 Gallacher et al. Apr 2014 A1
20140207052 Tal et al. Jul 2014 A1
20140207069 Bierman et al. Jul 2014 A1
20140214005 Belson Jul 2014 A1
20140257111 Yamashita et al. Sep 2014 A1
20140276432 Bierman et al. Sep 2014 A1
20140276599 Cully et al. Sep 2014 A1
20150011834 Ayala et al. Jan 2015 A1
20150080939 Adams et al. Mar 2015 A1
20150094653 Pacheco et al. Apr 2015 A1
20150112307 Margolis Apr 2015 A1
20150112310 Call et al. Apr 2015 A1
20150126930 Bierman et al. May 2015 A1
20150148595 Bagwell et al. May 2015 A1
20150190168 Bierman et al. Jul 2015 A1
20150196210 McCaffrey et al. Jul 2015 A1
20150224287 Bian et al. Aug 2015 A1
20150231364 Blanchard et al. Aug 2015 A1
20150283357 Lampropoulos et al. Oct 2015 A1
20150297868 Tal et al. Oct 2015 A1
20150320969 Haslinger et al. Nov 2015 A1
20150320977 Vitullo et al. Nov 2015 A1
20150351793 Bierman et al. Dec 2015 A1
20150359549 Lenker et al. Dec 2015 A1
20150359998 Carmel et al. Dec 2015 A1
20160082223 Barnell Mar 2016 A1
20160114124 Tal Apr 2016 A1
20160158523 Helm Jun 2016 A1
20160220786 Mitchell et al. Aug 2016 A1
20160242661 Fischell et al. Aug 2016 A1
20160256101 Aharoni et al. Sep 2016 A1
20160325073 Davies et al. Nov 2016 A1
20160331938 Blanchard Nov 2016 A1
20160338728 Tal Nov 2016 A1
20160346503 Jackson et al. Dec 2016 A1
20170028135 Fransson et al. Feb 2017 A1
20170035990 Swift Feb 2017 A1
20170072165 Lim et al. Mar 2017 A1
20170120000 Osypka et al. May 2017 A1
20170120014 Harding et al. May 2017 A1
20170120034 Kaczorowski May 2017 A1
20170128700 Roche Rebollo May 2017 A1
20170156987 Babbs et al. Jun 2017 A1
20170172653 Urbanski et al. Jun 2017 A1
20170182293 Chhikara et al. Jun 2017 A1
20170239443 Abitabilo et al. Aug 2017 A1
20170259043 Chan et al. Sep 2017 A1
20170273713 Shah et al. Sep 2017 A1
20170296792 Ornelas Vargas et al. Oct 2017 A1
20170326339 Bailey et al. Nov 2017 A1
20170361070 Hivert Dec 2017 A1
20170368255 Provost et al. Dec 2017 A1
20180001062 O'Carrol et al. Jan 2018 A1
20180008294 Garrison et al. Jan 2018 A1
20180021545 Mitchell et al. Jan 2018 A1
20180116690 Sarabia et al. May 2018 A1
20180117284 Appling et al. May 2018 A1
20180133438 Hulvershorn et al. May 2018 A1
20180154062 DeFonzo et al. Jun 2018 A1
20180154112 Chan et al. Jun 2018 A1
20180214674 Ebnet et al. Aug 2018 A1
20180296799 Horst et al. Oct 2018 A1
20180296804 Bierman Oct 2018 A1
20180310955 Lindekugel et al. Nov 2018 A1
20190015646 Matlock et al. Jan 2019 A1
20190021640 Burkholz et al. Jan 2019 A1
20190060616 Solomon Feb 2019 A1
20190076167 Fantuzzi et al. Mar 2019 A1
20190134349 Cohn et al. May 2019 A1
20190192824 Cordeiro et al. Jun 2019 A1
20190201665 Turpin Jul 2019 A1
20190209812 Burkholz et al. Jul 2019 A1
20190255294 Mitchell et al. Aug 2019 A1
20190255298 Mitchell et al. Aug 2019 A1
20190275303 Tran et al. Sep 2019 A1
20190276268 Akingba Sep 2019 A1
20190321590 Burkholz et al. Oct 2019 A1
20190351196 Ribelin Nov 2019 A1
20200001051 Huang et al. Jan 2020 A1
20200016374 Burkholz et al. Jan 2020 A1
20200046948 Burkholz et al. Feb 2020 A1
20200100716 Devgon et al. Apr 2020 A1
20200129732 Vogt et al. Apr 2020 A1
20200147349 Holt May 2020 A1
20200197682 Franklin et al. Jun 2020 A1
20200197684 Wax Jun 2020 A1
20200237278 Asbaghi Jul 2020 A1
20200359995 Walsh et al. Nov 2020 A1
20210030944 Cushen et al. Feb 2021 A1
20210060306 Kumar Mar 2021 A1
20210069471 Howell Mar 2021 A1
20210085927 Howell Mar 2021 A1
20210100985 Akcay et al. Apr 2021 A1
20210113809 Howell Apr 2021 A1
20210113810 Howell Apr 2021 A1
20210113816 DiCianni Apr 2021 A1
20210121661 Howell Apr 2021 A1
20210121667 Howell Apr 2021 A1
20210228842 Scherich et al. Jul 2021 A1
20210228843 Howell et al. Jul 2021 A1
20210244920 Kujawa et al. Aug 2021 A1
20210290898 Burkholz Sep 2021 A1
20210290901 Burkholz et al. Sep 2021 A1
20210290913 Horst et al. Sep 2021 A1
20210322729 Howell Oct 2021 A1
20210330941 Howell et al. Oct 2021 A1
20210330942 Howell Oct 2021 A1
20210361915 Howell et al. Nov 2021 A1
20210402149 Howell Dec 2021 A1
20210402153 Howell et al. Dec 2021 A1
20220001109 Simon Jan 2022 A1
20220001138 Howell Jan 2022 A1
20220032013 Howell et al. Feb 2022 A1
20220032014 Howell et al. Feb 2022 A1
20220062528 Thornley et al. Mar 2022 A1
20220062596 Ribelin Mar 2022 A1
20220126064 Tobin et al. Apr 2022 A1
20220193377 Haymond et al. Jun 2022 A1
20220193378 Spataro et al. Jun 2022 A1
20220323723 Spataro et al. Oct 2022 A1
20220331562 Jaros Oct 2022 A1
20220331563 Papadia Oct 2022 A1
20230042898 Howell et al. Feb 2023 A1
20230096377 West et al. Mar 2023 A1
20230096740 Bechstein et al. Mar 2023 A1
20230099654 Blanchard et al. Mar 2023 A1
20230100482 Howell Mar 2023 A1
20230101455 Howell et al. Mar 2023 A1
20230102231 Bechstein et al. Mar 2023 A1
20230173231 Parikh Jun 2023 A1
20230233814 Howell et al. Jul 2023 A1
20230381459 Belson Nov 2023 A1
20240009427 Howell et al. Jan 2024 A1
20240050706 Howell et al. Feb 2024 A1
20240198058 Howell et al. Jun 2024 A1
20250001136 Mitchell et al. Jan 2025 A1
20250065083 Haymond et al. Feb 2025 A1
20250082906 Howell et al. Mar 2025 A1
Foreign Referenced Citations (107)
Number Date Country
202012006191 Jul 2012 DE
0653220 May 1995 EP
0730880 Sep 1996 EP
2061385 May 2009 EP
1458437 Mar 2010 EP
2248549 Nov 2010 EP
2319576 May 2011 EP
2366422 Sep 2011 EP
2486880 Aug 2012 EP
2486881 Aug 2012 EP
2486951 Aug 2012 EP
2512576 Oct 2012 EP
2152348 Feb 2015 EP
3473291 Apr 2019 EP
3093038 May 2019 EP
2260897 Sep 2019 EP
3693051 Aug 2020 EP
1273547 May 1972 GB
2004248987 Sep 2004 JP
2008054859 Mar 2008 JP
9421315 Sep 1994 WO
9532009 Nov 1995 WO
9844979 Oct 1998 WO
9853871 Dec 1998 WO
WO-9857685 Dec 1998 WO
9912600 Mar 1999 WO
9926681 Jun 1999 WO
0006221 Feb 2000 WO
0054830 Sep 2000 WO
2003008020 Jan 2003 WO
2003057272 Jul 2003 WO
03068073 Aug 2003 WO
2003066125 Aug 2003 WO
2005096778 Oct 2005 WO
2006055288 May 2006 WO
2006055780 May 2006 WO
2007046850 Apr 2007 WO
2008033983 Mar 2008 WO
2008092029 Jul 2008 WO
2008131300 Oct 2008 WO
2008131289 Oct 2008 WO
2009114833 Sep 2009 WO
2009114837 Sep 2009 WO
2010048449 Apr 2010 WO
2010056906 May 2010 WO
2010083467 Jul 2010 WO
2010132608 Nov 2010 WO
2011081859 Jul 2011 WO
2011097639 Aug 2011 WO
2011109792 Sep 2011 WO
2011146764 Nov 2011 WO
2012068162 May 2012 WO
2012068166 May 2012 WO
2012135761 Oct 2012 WO
2012154277 Nov 2012 WO
2012162677 Nov 2012 WO
2013026045 Feb 2013 WO
2013138519 Sep 2013 WO
2014006403 Jan 2014 WO
2014100392 Jun 2014 WO
2014113257 Jul 2014 WO
2014152005 Sep 2014 WO
2014197614 Dec 2014 WO
2015057766 Apr 2015 WO
2015077560 May 2015 WO
2015168655 Nov 2015 WO
2016110824 Jul 2016 WO
2016123278 Aug 2016 WO
2016139590 Sep 2016 WO
2016139597 Sep 2016 WO
2016178974 Nov 2016 WO
2016187063 Nov 2016 WO
2016176065 Nov 2016 WO
2018089275 May 2018 WO
2018089285 May 2018 WO
2018089385 May 2018 WO
2018191547 Oct 2018 WO
2018213148 Nov 2018 WO
2018218236 Nov 2018 WO
2019050576 Mar 2019 WO
2019146026 Aug 2019 WO
2019199734 Oct 2019 WO
2020014149 Jan 2020 WO
2020069395 Apr 2020 WO
2020109448 Jun 2020 WO
2020113123 Jun 2020 WO
2021050302 Mar 2021 WO
WO-2021038041 Mar 2021 WO
2021077103 Apr 2021 WO
2021062023 Apr 2021 WO
2021081205 Apr 2021 WO
2021086793 May 2021 WO
2021236950 Nov 2021 WO
WO-2021226050 Nov 2021 WO
2022031618 Feb 2022 WO
2022094141 May 2022 WO
2022133297 Jun 2022 WO
2022-140406 Jun 2022 WO
2022140429 Jun 2022 WO
2022217098 Oct 2022 WO
2023014994 Feb 2023 WO
2023049498 Mar 2023 WO
2023049505 Mar 2023 WO
2023049511 Mar 2023 WO
2023049519 Mar 2023 WO
2023049522 Mar 2023 WO
2023146792 Aug 2023 WO
Non-Patent Literature Citations (87)
Entry
PCT/US2021/057135 filed Oct. 28, 2021 International Preliminary Report on Patentability dated May 2, 2023.
PCT/US2021/057135 filed Oct. 28, 2021 International Search Report and Written Opinion dated Mar. 11, 2022.
PCT/US2023/011173 filed Jan. 19, 2023 International Search Report and Written Opinion dated May 22, 2023.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 8, 2023.
U.S. Appl. No. 17/326,017, filed May 20, 2021 Notice of Allowance dated Jul. 3, 2023.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Restriction Requirement dated Jun. 7, 2023.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Restriction Requirement dated Jul. 20, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Jul. 17, 2023.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Aug. 9, 2023.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Non-Final Office Action dated Jul. 27, 2023.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Non-Final Office Action dated Oct. 4, 2023.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Oct. 13, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Jul. 27, 2023.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Restriction Requirement dated Oct. 3, 2023.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Board Decision dated Oct. 30, 2023.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated Jan. 18, 2024.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Restriction Requirement dated Jan. 18, 2024.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Notice of Allowance dated Oct. 27, 2023.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Dec. 6, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Dec. 1, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Nov. 21, 2023.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Non-Final Office Action dated Jan. 9, 2024.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Nov. 3, 2023.
PCT/US2021/028018 filed Apr. 19, 2021 International Preliminary Report on Patentability dated Jun. 3, 2022.
PCT/US2021/064174 filed Dec. 17, 2021 International Search Report and Written Opinion dated May 18, 2022.
PCT/US2021/064642 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 11, 2022.
PCT/US2021/064671 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 27, 2022.
PCT/US2022/024085 filed Apr. 8, 2022 International Search Report and Wirtten Opinion dated Sep. 12, 2022.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Examiner's Answer dated Oct. 31, 2022.
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Notice of Allowance dated Sep. 16, 2022.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Non-Final Office Action dated Oct. 25, 2022.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Notice of Allowance dated May 20, 2024.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Non-Final Office Action dated Apr. 23, 2024.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Advisory Action dated Feb. 22, 2024.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 4, 2024.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Final Office Action dated Mar. 13, 2024.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Feb. 14, 2024.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated May 6, 2024.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Jul. 5, 2024.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Advisory Action dated Feb. 14, 2024.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Apr. 23, 2024.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Final Office Action dated Jul. 9, 2024.
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Non-Final Office Action dated Apr. 19, 2024.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Final Office Action dated Feb. 29, 2024.
PCT/US2020/052536 filed Sep. 24, 2020 International Search Report and Written Opinion dated Dec. 4, 2020.
PCT/US2021/014700 filed Jan. 22, 2021 International Search Report and Written Opinion dated Jun. 29, 2021.
PCT/US2021/028018 filed Apr. 19, 2021 International Search Report and Written Opinion dated Sep. 13, 2021.
PCT/US2021/028683 filed Apr. 22, 2021 International Search Report and Written Opinion dated Sep. 16, 2021.
PCT/US2021/029183 filed Apr. 26, 2021 International Search Report and Written Opinion dated Sep. 24, 2021.
PCT/US2021/033443 filed May 20, 2021 International Search Report and Written Opinion dated Sep. 23, 2021.
PCT/US2021/039084 filed Jun. 25, 2021 International Search Report and Written Opinion dated Jan. 10, 2022.
PCT/US2021/044029 filed Jul. 30, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
PCT/US2021/044223 filed Aug. 2, 2021 International Search Report and Written Opinion dated Dec. 21, 2021.
PCT/US2021/048275 filed Aug. 30, 2021 International Search Report and Written Opinion dated Jan. 4, 2022.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Final Office Action dated May 30, 2018.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Jan. 25, 2019.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Nov. 2, 2017.
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Notice of Allowance dated May 15, 2019.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Final Office Action dated Jan. 25, 2022.
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated May 11, 2021.
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Non-Final Office Action dated May 11, 2022.
PCT/US2022/039614 filed Aug. 5, 2022 International Search Report and Written Opinion dated Dec. 22, 2022.
PCT/US2022/044848 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 3, 2023.
PCT/US2022/044879 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023.
PCT/US2022/044901 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023.
PCT/US2022/044918 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 21, 2023.
PCT/US2022/044923 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 15, 2023.
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Apr. 24, 2023.
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Restriction Requirement dated Feb. 1, 2023.
U.S. Appl. No. 17/326,017, filed May 20, 2021 Non-Final Office Action dated Jan. 26, 2023.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Mar. 2, 2023.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Restriction Requirement dated Mar. 30, 2023.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Final Office Action dated Sep. 20, 2024.
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Aug. 14, 2024.
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Notice of Allowance dated Jul. 17, 2024.
U.S. Appl. No. 17/461,619, filed Aug. 30, 2021 Restriction Requirement dated Dec. 6, 2024.
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Notice of Allowance dated Jul. 24, 2024.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Aug. 20, 2024.
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Notice of Allowance dated Dec. 16, 2024.
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Feb. 28, 2025.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Jan. 2, 2025.
U.S. Appl. No. 17/461,619, filed Aug. 30, 2021 Non-Final Office Action dated Feb. 11, 2025.
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Notice of Allowance dated Jan. 3, 2025.
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Notice of Allowance dated Dec. 11, 2024.
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Examiner's Answer dated May 1, 2025.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Advisory Action dated Mar. 12, 2025.
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Apr. 5, 2025.
Related Publications (1)
Number Date Country
20220193376 A1 Jun 2022 US
Provisional Applications (1)
Number Date Country
63128694 Dec 2020 US